0001213900-24-014197 Sample Contracts
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 15th, 2024 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 15th, 2024 Company IndustryThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [___], 2024, is by and among CERo Therapeutics Holdings, Inc. (f/k/a Phoenix Biotech Acquisition Corp.), a Delaware corporation with offices located at 201 Haskings Way, Suite 230, South San Francisco, CA 94080 (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
Standard Contracts
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 15th, 2024 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 15th, 2024 Company Industry
INVESTOR RIGHTS AND LOCK-UP AGREEMENTInvestor Rights and Lock-Up Agreement • February 15th, 2024 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 15th, 2024 Company IndustryThis INVESTOR RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”) is entered into as of [●], 2024, by and among Phoenix Biotech Acquisition Corp., a Delaware corporation, (the “Company”), and the parties listed as Investors on Schedule I hereto (each, including any person or entity who hereinafter becomes a party to this Agreement pursuant to Section 8.2, an “Investor,” and collectively, the “Investors”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Business Combination Agreement (as defined below).
SHARE REALLOCATION AGREEMENTShare Reallocation Agreement • February 15th, 2024 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 15th, 2024 Company Industry JurisdictionThis SHARE REALLOCATION AGREEMENT (this “Agreement”), dated as of [·], 2024, is made by and among Phoenix Biotech Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), Phoenix Biotech Acquisition Corp., a Delaware corporation (“SPAC”), and the undersigned investor (the “Investor”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).